64 related articles for article (PubMed ID: 32132214)
21. Optimizing the diagnosis and management of ductal prostate cancer.
Ranasinghe W; Shapiro DD; Zhang M; Bathala T; Navone N; Thompson TC; Broom B; Aparicio A; Tu SM; Tang C; Davis JW; Pisters L; Chapin BF
Nat Rev Urol; 2021 Jun; 18(6):337-358. PubMed ID: 33824525
[TBL] [Abstract][Full Text] [Related]
22. PDX: Moving Beyond Drug Screening to Versatile Models for Research Discovery.
Risbridger GP; Lawrence MG; Taylor RA
J Endocr Soc; 2020 Nov; 4(11):bvaa132. PubMed ID: 33094211
[TBL] [Abstract][Full Text] [Related]
23. Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.
Risbridger GP; Taylor RA; Clouston D; Sliwinski A; Thorne H; Hunter S; Li J; Mitchell G; Murphy D; Frydenberg M; Pook D; Pedersen J; Toivanen R; Wang H; Papargiris M; Lawrence MG; Bolton DM
Eur Urol; 2015 Mar; 67(3):496-503. PubMed ID: 25154392
[TBL] [Abstract][Full Text] [Related]
24. Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression.
Dawkins HJ; Sellner LN; Turbett GR; Thompson CA; Redmond SL; McNeal JE; Cohen RJ
Prostate; 2000 Sep; 44(4):265-70. PubMed ID: 10951489
[TBL] [Abstract][Full Text] [Related]
25. Knowing what's growing: Why ductal and intraductal prostate cancer matter.
Lawrence MG; Porter LH; Clouston D; Murphy DG; Frydenberg M; Taylor RA; Risbridger GP
Sci Transl Med; 2020 Mar; 12(533):. PubMed ID: 32132214
[TBL] [Abstract][Full Text] [Related]
26. A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma.
Cohen RJ; Wheeler TM; Bonkhoff H; Rubin MA
Arch Pathol Lab Med; 2007 Jul; 131(7):1103-9. PubMed ID: 17616999
[TBL] [Abstract][Full Text] [Related]
27. Intraductal carcinoma of the prostate.
Szentirmai E; Giannico GA
Pathologica; 2020 Mar; 112(1):17-24. PubMed ID: 32202536
[TBL] [Abstract][Full Text] [Related]
28. Molecular complexity of intraductal carcinoma of the prostate.
Zhu S; Xu N; Zeng H
Cancer Med; 2024 Jan; 13(2):e6939. PubMed ID: 38379333
[TBL] [Abstract][Full Text] [Related]
29. Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives.
Zong Y; Montironi R; Massari F; Jiang Z; Lopez-Beltran A; Wheeler TM; Scarpelli M; Santoni M; Cimadamore A; Cheng L
Eur Urol Focus; 2021 Sep; 7(5):955-963. PubMed ID: 33132109
[TBL] [Abstract][Full Text] [Related]
30. Intraductal carcinoma of the prostate.
Robinson B; Magi-Galluzzi C; Zhou M
Arch Pathol Lab Med; 2012 Apr; 136(4):418-25. PubMed ID: 22458904
[TBL] [Abstract][Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
